FC
Foresite Capital
Venture Capital · Founded 2011 · San Francisco, United States
Foresite Capital’s biggest current holdings.
The most valuable companies Foresite Capital still holds — unicorns and thoroughbreds it has backed, ordered by Dealroom’s latest valuation. Companies that have been acquired or gone public are in Exits instead. Where a cap table names Foresite Capital directly, the stake and its estimated value are shown too.
-
1
Color Health
—
$4.6B
—
-
2
Everly Health
—
$2.9B
—
-
3
Xaira Therapeutics
—
$2.7B
—
-
4
Insitro
—
$1.6B
—
-
5
Tessera Therapeutics
—
$1.5B
—
-
6
Kriya Therapeutics
—
$1.3B
—
-
7
Mammoth Biosciences
7%
$1.0B
$70M
-
8
Midi Health
—
$1.0B
—
-
9
Thyme Care
—
$1.0B
—
Estimated value = Foresite Capital’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →
Foresite Capital’s biggest exits.
Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Foresite Capital’s transaction record.
Where Foresite Capital’s portfolio is concentrated.
Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 121 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.
-
USA171
-
UK7
-
China2
-
Ireland2
-
Netherlands2
-
Canada1
-
Denmark1
-
Finland1
-
Germany1
-
Hong Kong1
-
Israel1
-
Japan1
-
Health189
-
Enterprise Software5
-
Wellness Beauty2
-
Chemicals1
-
Education1
-
Food1
-
Home Living1
-
Semiconductors1
-
Series B+87
-
Series A25
-
Seed2
-
Late Growth143
-
Breakout Stage36
-
Mature7
-
Early Growth5
Inside Foresite Capital’s portfolio.
The 60 highest-funded portfolio companies, of 121 tracked.
Pf
GR
No
EiXaKr
Cu
El
23
So
Pa
OdTe
Ob
Av
MaIn
Re
Ly
Al
SoCo
St
DN
Ol
Li
In
In
Qu
NG
Ab
Ad
Cu
CaMa
Af
Ta
De
Ju
De
Se
Ik
Ep
CG
Ge
Bi
Ju
Or
OR
La
Cr
Va
HiMi
GeEv
Co
Tw
Pe
RAWhere Foresite Capital’s portfolio founders come from.
177 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.
-
United States146
-
United Kingdom7
-
Canada3
-
Netherlands3
-
Germany2
-
Isle of Man2
-
Switzerland2
-
Australia1
-
France1
-
India1
-
Harvard University15
-
Massachusetts Institute of Technology13
-
Stanford University13
-
Harvard Business School5
-
University of California, Berkeley5
-
University of Pennsylvania5
-
Wharton School of the University of Pennsylvania5
-
Yale University5
-
Duke University4
-
Columbia University3
-
Genentech5
-
Alantos Pharmaceuticals4
-
Dana-Farber Cancer Institute4
-
GSK4
-
Lehman Brothers4
-
Brigham and Women's Hospital3
-
Lucentis3
-
Massachusetts Institute of Technology3
-
OrbiMed3
-
Sanofi Aventis3
Similar investors.
Peers the API surfaces as most similar by portfolio shape, with Dealroom investor rank and portfolio scale.
